Delivery Order SPE2DB22D2009-SPE2DB25FL7PB

Award Date 1/28/25
Potential Completion Date 1/29/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,017.05 delivery order contract is for the supply of 4,567,584,763 units of the drug Oseltamivir Phosphate 30 mg capsules. The contract has a period of performance through March 17, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,241.74, is for the delivery of 4,567,154,184 units of Oseltamivir Phosphate 75 mg capsules. The contract is a Firm Fixed Price Delivery Order, with a period of performance through February 5, 2025. No set-aside designation was used for this award. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a Ceiling Value of $3,189.12, is for the delivery of 4,567,197,325 units of the antiviral medication Oseltamivir Phosphate 75 mg capsules. The contract is a Firm Fixed Price Delivery Order with a completion date of February 10, 2025. This award is not designated as a set-aside contract....
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,465.27, is for the delivery of Oseltamivir Phosphate 75 mg capsules. It is a Firm Fixed Price Delivery Order contract, with a period of performance through February 24, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Oseltamivir Phosphate 75 mg capsules in unit doses of 10s, with a ceiling value of $2,657.60. The contract is a Firm Fixed Price Delivery Order, with a performance period ending on July 9, 2025. The contract is not set-aside and was awarded on July 8, 2025. AmerisourceBergen Drug Corp...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has an award value of $1,221.51 and is for the delivery of 4567199444 - OSELTAMIVIR PHOS 75 MG CAPSULE UD 10S. It is a firm fixed-price delivery order contract with a completion date of February 7, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Oseltamivir Phosphate 75 mg capsules. The Firm Fixed Price Delivery Order has a ceiling value of $2,635.20 and an ultimate completion date of November 15, 2022. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,987.17 firm fixed-price delivery order is for the purchase of 4,567,104,683 units of Oseltamivir Phosphate 75mg capsules, a medication used to treat influenza. The contract has an ultimate completion date of January 31, 2025 and was awarded on January 30, 2025. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,967,638 units of the antiviral medication Oseltamivir Phosphate 75 mg capsules in unit doses of 10s. The contract has a ceiling value of $3,593.78 and is a Firm Fixed Price Delivery Order with a period of performance ending on January 21, 2025. This award is not designated as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company and subsidiary of Cencora, Inc. The $5,902.51 firm-fixed-price delivery order is for the supply of Oseltamivir Phosphate 45 mg capsules, a medication used to treat influenza. The contract has an ultimate completion date of December 27, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB25FL7PB
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,074,564 units of oseltamivir phosphate 75 mg capsules. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,779.47 and a completion date of January 29, 2025. This award is not designated as a set-aside contract.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/21/25, 9:46 AM